Related Experiment Videos
Modulation of enterotoxin binding and function in vitro and in vivo
S T Donta1, P Damiano-Burbach, N J Poindexter
1Department of Medicine, University of Connecticut, Newington.
The Journal of Infectious Diseases
|March 1, 1988
Summary
Nontoxic B subunits of cholera and E. coli enterotoxins block toxin binding and effects by down-regulating cellular receptors. This offers short-term protection against enterotoxins, with administration requiring protection for small bowel delivery.
Area of Science:
- Microbiology
- Toxicology
- Pharmacology
Background:
- Cholera and E. coli enterotoxins cause significant gastrointestinal illness.
- Enterotoxin B subunits are nontoxic and can interfere with toxin binding.
Purpose of the Study:
- To investigate the efficacy of nontoxic enterotoxin B subunits in preventing toxin binding and effects.
- To elucidate the mechanism of B subunit-mediated inhibition of enterotoxin activity.
Main Methods:
- In vitro and in vivo experiments using B subunits of cholera and E. coli enterotoxins.
- Assessing toxin binding, receptor down-regulation, and toxin-induced cellular effects (morphological changes, adenylate cyclase activation, fluid secretion).
- Evaluating the duration and dose-dependency of B subunit inhibition.
Main Results:
- B subunit administration significantly decreased enterotoxin binding and subsequent effects.
- Inhibition resulted from cellular receptor down-regulation, not receptor occupancy.
- A single in vivo dose provided protection for up to 18 hours.
- Peroral administration requires protection to bypass the esophagus and stomach.
Conclusions:
- Nontoxic B subunits can be utilized for short-term therapeutic protection against enterotoxins.
- Understanding B subunit-receptor interactions is crucial for developing effective delivery strategies.
- B subunit therapy presents a potential strategy before an immune response develops.